Novosanis

Novosanis

www.novosanis.com

vanessa.vankerckhoven@novosanis.com

+32 3 485 50 16

Bijkhoevelaan 32 C

2110 Wijnegem

BE

Novosanis

Foundation date

12/03/2013

Sector

#Medical Technology

Subsector

Therapeutic areas

Novosanis designs and develops medical devices for a variety of applications, ranging from injection appliances to in vitro diagnostic accessories. Novosanis has two devices in its portfolio: VAX-ID, suited for injections of e.g. vaccines in the dermal layer of the skin and Colli-Pee, suited for collection of first void urine for detection of e.g. sexually transmitted infections and cancer. Novosanis aims to improve health and patient care and to offer a better quality of life through sustainable innovative technologies.

Upcoming events

Latest news

  • HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform

    Tuesday June 6th 2023

  • ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

    Monday June 5th 2023

  • Biotalys continues to demonstrate strength of first biocontrol in latest global field trials

    Friday June 2nd 2023

Jobs